Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing
About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ (daridorexant), a different kind of
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BGP Products Operations GmbH Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BGP Products Operations GmbH Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
Façonnez lavenir des soins de santé avec Abbott Abbott est un leader mondial des soins de santé dédié à aider les personnes à vivre leur meilleure vie à chaque étape. Notre portefeuille couvre des technologies révolutionnaires
Abbott, acteur mondial de la santé, recrute un Responsable principal HEOR & Preuves pour payereurs afin de façonner l’accès à des thérapies en oncologie et immunologie. Vous dirigerez des initiatives stratégiques à l’échelle mondiale et soutiendrez les
Position Summary The Senior Director, Head of Medical Evidence reports into the Vice President, Head of Disease Areas and coordinates with Medical Affairs and cross-functional stakeholders to lead the Integrated Evidence Generation Plans (IEGP) for all
Who We Are: Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed
At Genmab, we are dedicated to building extra(not)ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create,
The Chief Medical Officer (CMO) for Venous Pressure Solutions will serve as the clinical, scientific, and strategic leader driving the validation, adoption, and scaling of the solution. This executive will oversee clinical positioning, medical affairs, evidence
Revolution Medicines is seeking a Senior Director of Economic Modeling to lead the strategy and execution of health economic models across its portfolio. You will work with Global HEOR & RWE to support HTA submissions and payer
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
VP, Head of Global Access, Value and PricingLocation: Basel, BS, CHAbout Idorsia Pharmaceuticals LtdHeadquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is seeking a Director of Epidemiology, Europe to lead epidemiology plans across the product lifecycle. You will work with Clinical Development, Global Patient Safety, Medical Affairs, Regulatory, RWE/HEOR, Market Access and Commercial to provide epidemiologic